Press Releases on May 17, 2017 - EIN Presswire - Press Release Distribution Service

Published on May 17, 2017 - 21:19 GMT

Big 8 Split Inc. Announces Quarterly Dividends on Class D Preferred Shares and Class D Capital Shares

TORONTO, ON--(Marketwired - May 17, 2017) - Big 8 Split Inc. (the "Company") announced today that it has declared a quarterly dividend of $0.1125 per Class D Preferred Share. In addition, a quarterly dividend on its Class D Capital Shares was …

Distribution channels: Banking, Finance & Investment Industry

Published on May 17, 2017 - 21:19 GMT

Google and AppsFlyer Formalize Official Collaboration, Offering Marketers Better App Measurement Capabilities than Ever Before

SAN FRANCISCO, CA--(Marketwired - May 17, 2017) - AppsFlyer, the leading mobile attribution and marketing analytics company whose mission is to make the marketing industry more measureable, today announced its formal collaboration with Google as an App …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on May 17, 2017 - 21:19 GMT

Just Energy Reports Fourth Quarter and Full Year Fiscal 2017 Results

TORONTO, ONTARIO--(Marketwired - May 17, 2017) - Just Energy Group, Inc. (TSX:JE)(NYSE:JE), a leading retail energy provider specializing in electricity and natural gas commodities, energy efficiency solutions, and renewable energy options, today announced …

Distribution channels: Banking, Finance & Investment Industry, Energy Industry

Published on May 17, 2017 - 21:19 GMT

Cub Energy Inc. Announces Q1 2017 Financial and Operational Results

HOUSTON, TEXAS--(Marketwired - May 17, 2017) - Cub Energy Inc. ("Cub" or the "Company") (TSX VENTURE:KUB), a Ukraine-focused upstream oil and gas company, announced today its unaudited financial and operating results for the first …

Distribution channels: Energy Industry

Published on May 17, 2017 - 21:19 GMT

Enerflex Announces Two New Directors

CALGARY, ALBERTA--(Marketwired - May 17, 2017) - The Board of Directors of Enerflex Ltd. (TSX:EFX) ("Enerflex" or the "Company"), is pleased to announce the appointment of Ms. Maureen Cormier Jackson and Mr. Kevin Reinhart to the Board. …

Distribution channels: Energy Industry

Published on May 17, 2017 - 21:19 GMT

Movit Announces Non-Brokered Private Placement of up to $500,000; Closes Debt Conversion

VANCOUVER, BC--(Marketwired - May 17, 2017) - Movit Media Corp. (TSX VENTURE: MV) (the "Company") wishes to announce that it will be conducting a non-brokered private placement to raise up to $500,000 in funds (the "Offering"). The …

Distribution channels: IT Industry, Technology

Published on May 17, 2017 - 21:17 GMT

Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology (ASCO) ...

CAMBRIDGE, Mass., May 17, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported interim data from the Phase 1 study of DKN-01 in combination with …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:15 GMT

NTRP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors ...

NEW YORK, May 17, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Neurotrope, Inc. (“Neurotrope”) (NASDAQ:NTRP) between January 7, 2016 …

Distribution channels: Consumer Goods, Law

Published on May 17, 2017 - 21:16 GMT

ZIOPHARM Oncology Announces Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma to be Presented at the 2017 ASCO Annual ...

BOSTON, May 17, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter, dose-escalation study and 20-mg …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:11 GMT

Mitel Reports Voting Results from 2017 Annual Meeting of Shareholders

OTTAWA, May 17, 2017 (GLOBE NEWSWIRE) -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in enterprise communications, announced at its Annual Meeting of Shareholders held on May 15, 2017 the election of 8 nominees proposed for its Board of Directors, as …

Distribution channels: Telecommunications

Published on May 17, 2017 - 21:09 GMT

Affimed to Present Immune Cell Engager Data at ASCO Annual Meeting and EACR-AACR-SIC Special Conference

Heidelberg, Germany, May 17, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that data for Affimed's preclinical AFM24 and …

Distribution channels: Technology

Published on May 17, 2017 - 21:07 GMT

Syndax Announces Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) for the ...

-31% objective response rate for first stage of the Phase 2 melanoma cohort of ENCORE 601- -Enrollment ongoing in Stage 2, along with biomarker analysis- -ENCORE 601 now enrolling expanded cohorts of melanoma and NSCLC patients progressed on or after anti- …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:07 GMT

Merus Announces Promising Results from MCLA-128 Phase 1/2 Study in Metastatic Breast Cancer

Results to be presented at the 2017 American Society of Clinical Oncology Annual Meeting Phase 2 clinical trial to be initiated in second half of 2017 exploring two metastatic breast cancer populations: HER2-positive patients and hormone receptor-positive/ …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:05 GMT

TG Therapeutics, Inc. Recaps Clinical Data Presentations at the Upcoming 53rd Annual Meeting of the American Society of Clinical ...

NEW YORK, May 17, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that clinical abstracts featuring TG-1101 and TGR-1202 have been selected for presentation at the upcoming 53rd Annual Meeting of the American Society of …

Distribution channels: Conferences & Trade Fairs, Technology

Published on May 17, 2017 - 21:05 GMT

miRagen Therapeutics to Present New Clinical Trial Data for MRG-106, an Oligonucleotide Therapeutic Targeting microRNA-155, at the ...

BOULDER, Colo., May 17, 2017 (GLOBE NEWSWIRE) -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, announced today that new interim results from its …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology

Published on May 17, 2017 - 21:05 GMT

Data from Clinical Studies of NewLink Genetics’ Two Distinct IDO Pathway Inhibitors to Be Presented at ASCO 2017

AMES, Iowa, May 17, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that abstracts from two clinical studies of its IDO pathway inhibitors, indoximod and navoximod (GDC-0919), used in combination with other agents, are …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:02 GMT

Watching Your Language

By: Leslie G. Sarasin, President and CEO, Food Marketing Institute The following article appeared in the May/June 2017 Edition of Retail Leader. “Watch your language!” Chances are the last time you heard that admonition; it came from the lips of an older …

Distribution channels: Food & Beverage Industry

Published on May 17, 2017 - 21:01 GMT

Celldex Therapeutics to Present Clinical Results at 2017 ASCO Annual Meeting

HAMPTON, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that clinical results from the single-agent cohort of the Phase 2 study of glembatumumab vedotin in patients with metastatic melanoma and the Phase 1 …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:01 GMT

The efficacy of chemotherapy with epirubicin, one the of most used drugs in Breast Cancer can now be predicted by DRP - data ...

Hoersholm, Denmark, May 17th, 2017 - Medical Prognosis Institute A/S ("MPI") today announced that the previously warranted abstract with DRP data on epirubicin for breast cancer has been published electronically on the website of ASCO ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 17, 2017 - 21:00 GMT

Loxo Oncology Announces Details of Two Larotrectinib Clinical Data Oral Presentations at the 2017 American Society of Clinical ...

– Company to Host Conference Call and Webcast on Sunday, June 4th at 5:30PM CT – STAMFORD, Conn., May 17, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...